Comparing Standard Care With a New Computer Model to Predict and Reduce Postpartum Hemorrhage Risk

What this Trial Is About

Researchers are evaluating a new tool to predict the risk of postpartum hemorrhage PPH, a serious complication during and after childbirth. The study compares the current basic risk assessment method with an advanced model that uses 21 factors to calculate a more precise risk. This model updates automatically during labor and provides clinicians with a Best Practice Advisory BPA suggesting recommended actions when risk is elevated. Participants will receive standard care, including the usual category-based risk assessment. Those in the intervention group will also have the new risk prediction displayed, which triggers the BPA if the risk is 3% or higher. This advisory includes recommendations such as preventative use of tranexamic acid and second-line uterotonics, guiding providers without requiring mandatory actions. The study aims to see if this enhanced approach improves outcomes for mothers during childbirth. Throughout the study, researchers will collect data on postpartum morbidity and mortality from delivery until hospital discharge and up to 30 days after birth. They will monitor estimated blood loss, treatments for hemorrhage, blood transfusions, complications, and fetal APGAR scores at 1, 5, and 10 minutes. The total participation duration typically covers delivery through 30 days postpartum, focusing on the safety and health of both mother and baby.

A Pragmatic Randomized Controlled Trial to Predict Postpartum Hemorrhage